
ALS breakthrough: Ashwagandha-derived drug shows promise in slowing progression of amyotrophic lateral sclerosis
Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few effective treatments available to slow the progression …